Nuclear Medicine and Biology:
Official Journal of the SRS

Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.

If you are a member and experiencing difficulty accessing the journal online, please email Vidya Ramkumar [ussocieties(at)elsevier.com]. Vidya is our society liaison and typically responds in under 24 hours. You may also email our Executive Director, Charles Metzger [cmetzger(a)srsweb.org].

To gain complimentary access to the January 2021 special issue dedicated to Bill Eckelman, please select the image above or click here.


Volumes 144–145

May–June 2025

★ Editors Choice (Free Issue): Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177

František Trejtnar, Pavel Bárta, Ján Kozempel, Martin Vlk, Anna Ďurinová, Monika Kuchařová, Petr Pávek

Production and purification of radiolabeling-ready 132/135La from the irradiation of metallic natBa targets with low energy protons

E.S. Kurakina, B.L. McNeil, J. Khushvaktov, N.T. Temerbulatova, ... V. Radchenko

Quantitative imaging using [18F]F-TZ3108 to assess metabolic-associated fatty liver disease progression and low-carbohydrate diet efficacy

Zongping Han, Min Yang, Lei Bi, Peizhen Ye, ... Jinyu Xia

Radiolabeling yield dependency of post-dry distillation decay of astatine-211

Ellinor Hansson, Chiara Timperanza, Holger Jensen, Björn Eriksson, ... Emma Aneheim

Longitudinal multi-tracer imaging of hepatocellular carcinoma identifies novel stage- and oncogene-specific changes

Mari Teuter, Yuhai Hu, Tobias L. Ross, Kelsey Lolatte, ... Jens P. Bankstahl

Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques

Takanori Sasaki, Sadaaki Kimura, Akihiro Noda, Yoshihiro Murakami, ... Eiji Matsuura

IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals

A.R. Jalilian, J. Kleynhans, P. Bouziotis, F. Bruchertseifer, ... V. Radchenko

How green are radiopharmaceutical sciences?

Verena Pichler, Matthias Manfred Herth, Verena Hugenberg, Peter J.H. Scott, ... Giancarlo Pascali

Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans

Benjamin B. Tournier, Zahra Mansouri, Yazdan Salimi, Kelly Ceyzériat, ... Philippe Millet

Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy

Anja Charlotte Lundgren Mortensen, Camilla Hofström, Helena Persson, Leif Dahllund, ... Marika Nestor

Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study

Kengo Sato, Tomoyasu Bunai, Akinori Oda, Hiroyuki Ohba, ... Yasuomi Ouchi
 

Volumes 142–143

March–April 2025

★ Editors Choice (Free Issue): Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus

Editorial Board

Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci

Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115

[18F]BCPP-EF positron emission tomography of rat ovaries for evaluation of mitochondrial function

Corrigendum to “Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy” [Nucl Med Biol (March–April 2025) 108990]

PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model

Solid phase extraction chromatography-based radiochemical isolation of cyclotron-produced 51Mn from enriched 54Fe targets

Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy

Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production

Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information